Skip to main navigation Skip to search Skip to main content

Palbociclib Is Safe for Breast Cancer Patients With Mild Hepatic Impairment: A Multicenter Retrospective Study Using Real-World Data

  • Alieke K. Bos*
  • , Annelieke E.C.A.B. Willemsen
  • , Loes E. Visser
  • , Lennart J. Stoker
  • , Jurjen S. Kingma
  • , Mirjam K. Rommers
  • , Emile M. Kuck
  • , Paul D. van der Linden
  • , Merel van Nuland
  • *Corresponding author for this work
  • Tergooi Medisch Centrum
  • Haga Teaching Hospital
  • Haaglanden Medisch Centrum
  • Ziekenhuisgroep Twente
  • North West Hospital Group
  • Diakonessenhuis Utrecht

Research output: Contribution to journalArticleAcademicpeer-review

45 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Palbociclib Is Safe for Breast Cancer Patients With Mild Hepatic Impairment: A Multicenter Retrospective Study Using Real-World Data'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science